These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27362817)

  • 21. CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D+/R+ Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction Therapy.
    Jarque M; Melilli E; Crespo E; Manonelles A; Montero N; Torras J; Cruzado JM; Luque S; Gil-Vernet S; Grinyó JM; Bestard O
    Transplantation; 2018 Nov; 102(11):e472-e480. PubMed ID: 30130330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and risk factors for cytomegalovirus disease in a Colombian cohort of kidney transplant recipients.
    Díaz J; Henao J; Rodelo J; García A; Arbeláez M; Jaimes F
    Transplant Proc; 2014; 46(1):160-6. PubMed ID: 24507044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation analysis of survival period and CD4+ Tcell-iATP levels in liver transplant recipients].
    Qu W; Sun L; Zhu Z; Liu Y; Wei L; Zeng Z
    Zhonghua Gan Zang Bing Za Zhi; 2014 Sep; 22(9):693-7. PubMed ID: 25369255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients.
    Fernández-Ruiz M; Silva JT; López-Medrano F; Allende LM; San Juan R; Cambra F; Justo I; Paz-Artal E; Jiménez C; Aguado JM
    Transpl Infect Dis; 2016 Aug; 18(4):552-65. PubMed ID: 27260953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study.
    Fernández-Ruiz M; Origüen J; Lora D; López-Medrano F; González E; Polanco N; San Juan R; Ruiz-Merlo T; Parra P; Andrés A; Aguado JM
    Transpl Int; 2018 Feb; 31(2):187-197. PubMed ID: 28940695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation Between Survival Interval and CD4
    Qu W; Zhu ZJ; Sun LY; Wei L; Liu Y; Zeng ZG
    Transplant Proc; 2017 Mar; 49(2):316-321. PubMed ID: 28219591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation.
    Fernández-Ruiz M; López-Medrano F; Allende LM; Andrés A; García-Reyne A; Lumbreras C; San-Juan R; Morales JM; Paz-Artal E; Aguado JM
    Transpl Int; 2014 Jul; 27(7):674-85. PubMed ID: 24650360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
    Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
    Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis.
    Stevens DR; Sawinski D; Blumberg E; Galanakis N; Bloom RD; Trofe-Clark J
    Transpl Infect Dis; 2015 Apr; 17(2):163-73. PubMed ID: 25661673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic of the CMV-specific T-cell immune response and CMV infection in CMV-seropositive kidney transplant recipients receiving rabbit anti-thymocyte globulin induction therapy: A pilot study.
    Martín-Gandul C; Pérez-Romero P; Mena-Romo D; Molina-Ortega A; González-Roncero FM; Suñer M; Bernal G; Cordero E;
    Transpl Infect Dis; 2018 Jun; 20(3):e12883. PubMed ID: 29570917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a Predictive Model Using Endoscopic Features for Gastric Cytomegalovirus Infection in Renal Transplant Patients.
    Yeo SJ; Kwon KT; Kim ES; Jung MK; Kim SK; Lee HS; Lee JS; Lee SW; Lee YJ; Kwak SG; Han S
    Transplantation; 2019 May; 103(5):998-1004. PubMed ID: 30507742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression.
    Alkhouri N; Hanouneh IA; Lopez R; Zein NN
    Liver Transpl; 2010 Feb; 16(2):155-62. PubMed ID: 20104483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients.
    Lee YM; Kim YH; Han DJ; Park SK; Park JS; Sung H; Hong HL; Kim T; Kim SH; Choi SH; Kim YS; Woo JH; Lee SO
    Transpl Infect Dis; 2014 Jun; 16(3):397-402. PubMed ID: 24810355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection.
    Eid AJ; Brown RA; Arthurs SK; Lahr BD; Eckel-Passow JE; Larson TS; Razonable RR
    Transpl Int; 2010 May; 23(5):506-13. PubMed ID: 19951371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of CMV-specific cell-mediated immunity with a commercial ELISA-based interferon-γ release assay in kidney transplant recipients treated with antithymocyte globulin.
    Fernández-Ruiz M; Rodríguez-Goncer I; Parra P; Ruiz-Merlo T; Corbella L; López-Medrano F; Polanco N; González E; San Juan R; Folgueira MD; Andrés A; Aguado JM
    Am J Transplant; 2020 Aug; 20(8):2070-2080. PubMed ID: 31991045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection.
    Huskey J; Gralla J; Wiseman AC
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):423-9. PubMed ID: 21088287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients.
    Rittà M; Costa C; Sidoti F; Ballocco C; Ranghino A; Messina M; Biancone L; Cavallo R
    New Microbiol; 2015 Jul; 38(3):329-35. PubMed ID: 26147141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
    Couzi L; Thiébaut R; Carron JC; Moreau JF; Merville P; Taupin JL
    Transplantation; 2008 Oct; 86(8):1060-7. PubMed ID: 18946343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
    Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
    Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.